Google launches $250 per month ‘VIP’ AI subscription service

Google launches 0 per month ‘VIP’ AI subscription service


Alphabet CEO Sundar Pichai during the Google I/O developers conference in Mountain View, California, on May 10, 2023.

David Paul Morris | Bloomberg | Getty Images

Google is adding a new artificial intelligence subscription service that offers exclusive access to the company’s most “cutting edge” AI products.

Called “Google AI Ultra,” the new plan includes the highest usage limits and access to its latest AI models and premium features, the company announced Tuesday at its annual developer conference Google IO.

At $249.99 per month, the subscription plan also includes early access features to experimental products as well as a YouTube premium subscription.

“It’s for the trailblazers, the pioneers, those of you who want cutting-edge AI from Google,” Josh Woodward, head of product incubator Google Labs and the Gemini app, said at the event. “You can think of this Ultra plan as your VIP pass for Google AI.”

The plan offers a “massive” 30 terabytes of storage, he said.

Google charges for some premium versions of cloud services and AI products under a tier called “Google One AI Premium,” which can cost between $19.99 and $149.99 per month depending on storage size.

Google AI Ultra could attract premium users willing to pay a larger price to use Google’s products as the company tries to monetize its AI products and diversify revenue streams amid market changes.

Read more CNBC reporting on AI

Alphabet’s revenue growth from advertising, while still strong, has decelerated in recent years. That’s in addition to facing the growing threat of users increasingly shifting to search for information on AI chatbots created by companies like OpenAI’s ChatGPT.

OpenAI last December launched ChatGPT Pro, a $200 monthly plan that allows “scaled access” to OpenAI’s best models and tools.

Google AI Ultra includes the company’s flagship AI app Gemini with the newly-announced Gemini 2.5 Pro “DeepThink” mode, which can be used for deep research, Woodward said. It will also include the new filmmaking AI tool Flow, and note-to-podcast tool Notebook LM with the highest limit.

Alphabet CEO Sundar Pichai speaks at the company’s annual developer conference I/O in Mountain View, California, U.S., May 20, 2025.

Jeffrey Dastin | Reuters

It will continually include “a lot of other early access features,” Woodward said.

The Ultra plan also includes more experimental projects like Project Mariner, an agent research prototype that can help a user do up to 10 tasks simultaneously, as well as the latest Gemini models and early access to its Veo 3, the company’s newly announced video generation tool, the company said.

The Ultra plan will be available in the U.S. starting Tuesday, and rolling out to other countries in the coming months, the company said.



Source

Stock futures are little changed as Wall Street eyes latest developments in Middle East and oil prices: Live updates
World

Stock futures are little changed as Wall Street eyes latest developments in Middle East and oil prices: Live updates

A trading floor manager works on the floor of the American Stock Exchange (AMEX) at the New York Stock Exchange (NYSE) in New York, US, on Monday, May 4, 2026. Michael Nagle | Bloomberg | Getty Images U.S. stock futures were little changed on Monday night after the major averages suffered declines amid growing concerns […]

Read More
CNBC’s The China Connection newsletter: China is rewiring the Silicon Valley model — starting in Hong Kong
World

CNBC’s The China Connection newsletter: China is rewiring the Silicon Valley model — starting in Hong Kong

Hi, this is Evelyn, writing to you from Beijing. Welcome to the latest edition of The China Connection — a succinct snapshot of what I’m seeing and hearing from local businesses. My latest conversations with investors reveal a notable shift: China has taken note of how finance powered Silicon Valley’s rise and is following suit. […]

Read More
Novo Nordisk’s Wegovy pill head start forces investors to rethink Eli Lilly’s GLP-1 dominance
World

Novo Nordisk’s Wegovy pill head start forces investors to rethink Eli Lilly’s GLP-1 dominance

Still life of the new Wegovy semaglutide tablets on a white background. Its a prescription medicine used with a reduced calorie diet and .and physical activity. Michael Siluk | Universal Images Group | Getty Images When the Wegovy pill launched in January, telehealth provider LifeMD said its business doubled almost overnight.  LifeMD went from seeing […]

Read More